Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
Maqola

[PP.12.17] ANTIHYPERTENSIVE EFFICACY OF TRIPLE DRUGS FIXED COMBINATION THERAPY OF HIGH-RISK HYPERTENSIVE PATIENTS

Alexander NagayRepublican Specialized Center of Cardiology Tashkent, Uzbekistan, Tashkent, UzbekistanGulnoz KhamidullaevaRepublican Specialized Center of Cardiology Tashkent, Uzbekistan, Tashkent, UzbekistanG. AbdullaevaRepublican Specialized Center of Cardiology Tashkent, Uzbekistan, Tashkent, UzbekistanL. KhafisovaRepublican Specialized Center of Cardiology Tashkent, Uzbekistan, Tashkent, Uzbekistan
Journal of Hypertensionjournal2017en
ABI

Annotatsiya

Objective: Evaluate antihypertensive efficacy triple drugs fixed combination of indapamide, perindoprile and amlodipine in high-risk hypertensive patients during 12 weekly therapy. Design and method: The study included 22 high-risk hypertensive patients (II-III stage of essential hypertension, ESH/ESC 2013) who were resistant to bi-combination antihypertensive therapy, in average age 56.9 ± 9.2 years. All patients were administrated fixed combination of indapamide 1.7 ± 0.61 mg, perindoprile 6.54 ± 2.42 mg and amlodipine 6.81 ± 2.46 mg daily (Triplixam, “Servier”) within 12 weeks. Blood pressure (BP) measured by Korotkov method and 24-h ambulatory BP monitoring (ABPM) was performed. Results: By the end of the 12-weekly therapy was observed significantly reduce of systolic and diastolic BP (SBP and DBP) in both ambulatory and office measurements. During the therapy office SBP reduced on 23.4 ± 5.77% (from 165.95 ± 14.73 mmHg to 126.6 ± 7.92 mmHg, p = 0.0001), and DBP reduced on 21.37 ± 7.12% (from 101.36 ± 8.88 mmHg to 79.31 ± 5.83 mmHg, p = 0.0001). 86.4% of patients were achieved a target BP level <140/90 mmHg on office measurements. The results of 24-h ABPM shown normalization rates of 24-h BP, daytime BP and significantly reduce of nighttime BP. Thus, 24-h SBP reduced from 142.55 ± 12.9 mmHg to 128.61 ± 12.65 mmHg, p = 0.0001 and 24-h DBP from 88.0 ± 10.7 mmHg to 78.61 ± 8.43 mmHg, p = 0.002. High antihypertensive efficacy of triple drugs fixed combination characterized with significantly reduce high daily (24-h) BP variability from 18.35 ± 5.57 mmHg to 14.72 ± 3.71, p = 0.015 for SBP and from 13.86 ± 3.08 to 12.17 ± 2.4 mmHg, p = 0.043 for DBP. Conclusions: The results of our study have shown that 86.4% of high-risk hypertensive patients achieved BP goals with normalization of 24-h ABPM indexes such 24-h SBP, DBP and daily variability of SBP and DBP during 12-weekly therapy with Triplixam.

Hali tarjima qilinmagan

Mavzular

Identifikatorlar

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba
Koʻrsatkichlar — AkademScholar · Tez orada